MPK-1, also known as MAP kinase or ERK, is a key component of the MAP kinase signaling pathway involved in cellular responses to various extracellular stimuli. Inhibiting MPK-1 can be achieved using several chemical inhibitors that target different components of its signaling pathway. PD 98059 and U0126 are selective inhibitors of the MAP kinase kinase (MEK) pathway, which can inhibit MPK-1 by blocking its activation through the upstream MEK kinase. By preventing the phosphorylation and activation of MPK-1, these inhibitors effectively inhibit its downstream signaling. SB 203580, SB 202190, and SB 239063 are specific inhibitors of p38 MAP kinase, which indirectly inhibit MPK-1. By targeting p38 MAP kinase, these inhibitors disrupt the signaling pathways that converge on MPK-1 and inhibit its activation. SP600125, JNK Inhibitor V, JNK Inhibitor XVI, and JNK-IN-7 are selective inhibitors of c-Jun N-terminal kinase (JNK), which indirectly inhibit MPK-1. JNK can activate MPK-1 through a signaling cascade, and by inhibiting JNK, the activation of MPK-1 is prevented.
ERK Inhibitor II, FR180204 is a selective inhibitor of ERK1/2, which are closely related to MPK-1. By inhibiting ERK1/2, ERK Inhibitor II, FR180204 indirectly inhibits MPK-1 and disrupts its downstream signaling. BIX 02189 and PD 0325901 are selective inhibitors of MEK1/2, which are upstream kinases of MPK-1. By inhibiting MEK1/2, these inhibitors prevent the activation of MPK-1 and inhibit its downstream signaling. In summary, MPK-1 inhibitors can directly target the activation of MPK-1 by inhibiting its upstream kinases, such as MEK1/2, or indirectly target MPK-1 by inhibiting other components of its signaling pathway, such as p38 MAP kinase or JNK. By inhibiting MPK-1, these inhibitors disrupt its downstream signaling and can potentially impact cellular processes such as cell proliferation, differentiation, and survival. The specific choice of inhibitor depends on the desired target within the MAP kinase pathway and the specific experimental context.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a selective inhibitor of the MAP kinase kinase (MEK) pathway, which can inhibit MPK-1 by blocking its activation through the upstream MEK kinase. This prevents the phosphorylation and activation of MPK-1, thereby inhibiting its downstream signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a specific inhibitor of p38 MAP kinase, which can indirectly inhibit MPK-1. By targeting p38 MAP kinase, SB203580 can disrupt the signaling pathways that converge on MPK-1 and inhibit its activation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a selective inhibitor of c-Jun N-terminal kinase (JNK), which can indirectly inhibit MPK-1. JNK can activate MPK-1 through a signaling cascade, and by inhibiting JNK with SP600125, the activation of MPK-1 is prevented. | ||||||
ERK Inhibitor II, FR180204 | 865362-74-9 | sc-203945 sc-203945A sc-203945B sc-203945C | 1 mg 5 mg 10 mg 50 mg | $110.00 $165.00 $239.00 $942.00 | 45 | |
ERK Inhibitor II, FR180204 is a selective inhibitor of ERK1/2, which are closely related to MPK-1. By inhibiting ERK1/2, it can indirectly inhibit MPK-1 and disrupt its downstream signaling. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
SB 202190 is a selective inhibitor of p38 MAP kinase. By targeting p38 MAP kinase, SB 202190 can indirectly inhibit MPK-1 and disrupt its downstream signaling. | ||||||
BIX 02189 | 1094614-85-3 | sc-364436 sc-364436A | 5 mg 10 mg | $224.00 $386.00 | 5 | |
BIX 02189 is a selective inhibitor of MEK1/2, which are upstream kinases of MPK-1. By inhibiting MEK1/2, BIX 02189 can prevent the activation of MPK-1 and inhibit its downstream signaling. | ||||||
JNK Inhibitor XVI | 1410880-22-6 | sc-364745 | 10 mg | $357.00 | 5 | |
JNK Inhibitor XVI is a potent inhibitor of JNK. By inhibiting JNK, it can indirectly inhibit MPK-1 and disrupt its downstream signaling. | ||||||
JNK Inhibitor V | 345987-15-7 | sc-202672A sc-202672 | 1 mg 5 mg | $60.00 $169.00 | 3 | |
AS601245 is an ATP-competitive JNK inhibitor. By targeting JNK, it can indirectly inhibit MPK-1 and disrupt its downstream signaling. | ||||||
SB 239063 | 193551-21-2 | sc-220094B sc-220094 sc-220094A | 500 µg 5 mg 25 mg | $119.00 $162.00 $645.00 | 7 | |
SB 239063 is a selective inhibitor of p38 MAP kinase. By inhibiting p38 MAP kinase, SB 239063 can indirectly inhibit MPK-1 and disrupt its downstream signaling. | ||||||